Pay in 4 interest-free payments of $7.32 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
Wavelength of light: 589.3 nm
The trade-off is ongoing cost and the commitment to continued medication use
Diabetes, Obesity & Metabolism, 22(3), 442-451
Amneal is leveraging its leading product development and manufacturing capabilities in the rapidly growing GLP-1 therapeutic category, said Andy Boyer, Executive Vice President, Chief Commercial Officer - Generics.
The ARAMIS trial demonstrated a significant benefit for the novel androgen receptor (AR) antagonist darolutamide in non-metastatic castration-resistant prostate cancer 8
Molecular mechanisms of mTOR-mediated translational control
US$ 26.68
US$ 25.63
US$ 29.78
